Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sutherland

Showing results (421-430 of 428) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 428 results.
International Journal of Cancer|March 24, 2010
p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5Takahiko Kobayashi, Junich Ishida, Manabu Musashi, et al.
BMC Molecular Biology|July 22, 2017
Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNALeslie C Sutherland, Philippe Thibault, Mathieu Durand, et al.
JCI Insight|May 4, 2018
Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairmentGraciela Andonegui, Erin L Zelinski, Courtney L Schubert, et al.
Marine Pollution Bulletin|February 24, 2024
Marine turtles as bio-indicators of plastic pollution in the eastern MediterraneanEmily M Duncan, Hasan Deniz Akbora, Patrizia Baldi, et al.
Blood Advances|May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS InvolvementIbrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Transplantation and Cellular Therapy|June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Blood Advances|June 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALLTamer Othman, Gregory W Roloff, Katharine Miller, et al.
Blood|February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After BrexucabtageneHrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Pageof 43

Showing results (421-430 of 428) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 428 results.
International Journal of Cancer|March 24, 2010
p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5Takahiko Kobayashi, Junich Ishida, Manabu Musashi, et al.
BMC Molecular Biology|July 22, 2017
Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNALeslie C Sutherland, Philippe Thibault, Mathieu Durand, et al.
JCI Insight|May 4, 2018
Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairmentGraciela Andonegui, Erin L Zelinski, Courtney L Schubert, et al.
Marine Pollution Bulletin|February 24, 2024
Marine turtles as bio-indicators of plastic pollution in the eastern MediterraneanEmily M Duncan, Hasan Deniz Akbora, Patrizia Baldi, et al.
Blood Advances|May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS InvolvementIbrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Transplantation and Cellular Therapy|June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Blood Advances|June 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALLTamer Othman, Gregory W Roloff, Katharine Miller, et al.
Blood|February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After BrexucabtageneHrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Pageof 43